Lmcg Investments LLC Buys 6,117 Shares of Agilent Technologies, Inc. $A

Lmcg Investments LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 6.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 105,340 shares of the medical research company’s stock after acquiring an additional 6,117 shares during the quarter. Agilent Technologies makes up about 1.0% of Lmcg Investments LLC’s portfolio, making the stock its 29th biggest position. Lmcg Investments LLC’s holdings in Agilent Technologies were worth $18,151,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in A. SHP Wealth Management bought a new position in shares of Agilent Technologies in the 4th quarter worth $26,000. Cedar Mountain Advisors LLC purchased a new stake in shares of Agilent Technologies during the 1st quarter worth $27,000. Markowski Investments bought a new stake in Agilent Technologies during the second quarter valued at about $27,000. Keating Financial Advisory Services Inc. bought a new stake in Agilent Technologies during the second quarter valued at about $31,000. Finally, MidFirst Bank bought a new stake in Agilent Technologies during the fourth quarter valued at about $33,000.

Insider Buying and Selling

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This trade represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Agilent Technologies Stock Performance

Shares of A opened at $177.93 on Thursday. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $178.21. The stock has a fifty day moving average price of $160.50 and a 200-day moving average price of $138.97. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The firm has a market cap of $50.16 billion, a PE ratio of 35.03, a P/E/G ratio of 2.63 and a beta of 1.21.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same quarter last year, the firm earned $1.37 EPS. The business’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be paid a $0.2550 dividend. The ex-dividend date is Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is 20.08%.

Analyst Ratings Changes

A has been the topic of several analyst reports. Barclays lifted their target price on Agilent Technologies from $175.00 to $195.00 and gave the company an “overweight” rating in a research note on Wednesday, October 7th. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Royal Bank Of Canada increased their price target on shares of Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. UBS Group initiated coverage on shares of Agilent Technologies in a research report on Wednesday, September 9th. They set a “neutral” rating and a $165.00 price target for the company. Finally, Bank of America raised their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Fifteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $173.65.

Agilent Technologies Company Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.